As of Jul 31
| +0.57 / +0.55%|
The 29 analysts offering 12-month price forecasts for Novartis have a median target of 114.23, with a high estimate of 123.00 and a low estimate of 92.78. The median estimate represents a +10.10% increase from the last price of 103.75.
The current consensus among 32 polled investment analysts is to Buy stock in Novartis. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.